Real-time Image Processing Enables Software-Only Guidance and Verification in Minimally Invasive Spine Surgery RA’ANANA, Israel--(BUSINESS WIRE)--VUZE Medical, a privately held medical technology company aimed at transforming image guidance and verification in...
AUSTIN, Texas, Jan. 18, 2022 /PRNewswire/ -- Genesys Spine, a medical device manufacturer based in Austin, Texas, announced today that their SI Joint division exceeded 2021 sales targets: a 184% growth over 2020. "We are...
SANUWAVE will hold a conference call on Wednesday, January 19, 2022, at 9am ET to discuss its recent business activity SUWANEE, GA, Jan. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health,...
If 2020 was a challenging year for global mergers and acquisitions with the Covid-19 pandemic impacting dealmakers, the orthopaedic market showed few signs of slowing down in 2021. After an unpredictable...
Amplify Surgical partners with expert surgeons from South Korea and the US to demonstrate one of the latest advancements in minimally invasive spine surgery, the dualPortal approach. IRVINE, CALIF. (PRWEB) JANUARY 17,...
Lund, Sweden, 15:30 CET, 22-01-13 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has entered into a distribution agreement with...
The investment enables Texas-area orthopedic and spine practices to maintain autonomy while achieving the benefits of scale and serves as a cornerstone for Novum’s new orthopedic practice management platform DALLAS &...
San Francisco and Fort Worth, Texas – December 16, 2021 – TPG, a leading global alternative asset firm, announced today that it has publicly filed a registration statement on Form S-1...
Disior advances Paragon 28’s SMART 28™ strategy, providing a comprehensive 3D analytics and pre-operative planning platform, and will immediately accelerate internal research programs. ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“Paragon...
MELVILLE, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on stem cell-based therapies, today announced that Robert Paccasassi...